Probiotic Approach to Combat multi-resistant Enterococci: A Cross-over Trial on the Effect of Probiotics on Nosocomial Spread of CC17 Enterococcus faecium

Probiotic Approach to Combat multi-resistant Enterococci: A Cross-over Trial on the Effect of Probiotics on Nosocomial Spread of CC17 Enterococcus faecium - PACE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30711

Enrollment

640

Registered

2007-04-25

Start date

2007-02-05

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonization

Interventions

During period B probiotics are added to the diet of all admissions to the study ward twice daily. During period A patients will not receive probiotics

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All admissions during the study periods on 2 wards with a high prevalence of intestinal ARE-colonization: the geriatric and gastroenterology/nephrology wards of the UMCU.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Primary endpoint: the difference in acquisition rate of intestinal ARE-colonization between periods A and B.	—

Secondary

Measure	Time frame
Secondary endpoint: the difference in endemic prevalence of intestinal ARE-colonization between periods A and B.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)